- Global Pharma News & Resources

COEUS Holdings Appoints Daniel Garrett as Independent Board Member

Appointment Adds Additional Oversight and Guidance Along with Unparalleled Expertise in Growing Technology Applications and Businesses

DEVON, Pa.--(BUSINESS WIRE)--COEUS Holdings and its subsidiaries, together a leading health outcomes, contracting, technology and commercial insights consulting firm, today announced it has appointed Daniel Garrett to its board as an independent director. Mr. Garrett joins the COEUS board after a successful career in healthcare as PwC’s Technology Consulting Leader for PwC US & Trifecta (US, China/HK, and Japan). Dan also serves on the Board of Directors of the eHealth Initiative as a leader driving healthcare transformation, convening leaders from across the healthcare industry.

At PwC, Dan had cross-industry responsibility of refining and executing strategy and overseeing all of PwC's Technology Consulting Functions. In addition, Dan served as the US leader of the Health Industries IT (HIT) practice and was their global Health Industries Analytics Lead, with responsibility for coordinating the practice across the PwC network. In that capacity Dan lead all analytics, digital, and cyber security initiatives, as well as Tech Consulting efforts. The HIT practice has been ranked by multiple industry analysts as a leading HIT consulting firm, with the greatest depth and breadth of expertise. He came to PwC from CSC, where he was the EVP and Managing Partner leading CSC’s healthcare practice.

“Dan’s proven leadership at the board level will be a tremendous asset to the organization as we continue to scale and build the COEUS family of companies into a world class organization,” said Marc Hixson, CEO of COEUS Holdings. “In addition, his experience in healthcare technology will be instrumental as we continue to grow our client base and offerings around COEUS HealthCare’s recently launched COEBRA platform focused on supporting the healthcare industry’s movement towards value by demonstrating the clinical and cost effectiveness of life-saving products, as well as our technology offerings being built and implemented by COEUS Solutions.”

“I am truly pleased to be joining the COEUS board during a time of exponential growth within the organization and look forward to contributing my knowledge and experience to the organization,” said Mr. Garrett. “The team that COEUS has been able to assemble to date is second to none and combined with the technology solutions the company has/are developing will ensure they are a market leader in ensuring patients have access to appropriate therapies when needed.”

About COEUS Holdings

The COEUS Holdings teams are singularly driven to optimize market access and commercialization infrastructure for pharmaceutical products. COEUS is a multi-specialty, commercially aligned consultancy, offering a comprehensive suite of informed solutions for successful engagement with organized customers, providers, and patients. Leveraging years of collective real-world market expertise, we offer unique perspectives into clinical and business opportunities to support your brands’ position in the marketplace. COEUS' mission is to ensure patient access beyond the prescription. We focus on becoming your ally in navigating the healthcare universe. COEUS teams advance thought leadership, technology solutions, and communication initiatives to ensure your brands’ lifelong success. Together, we strive to redefine access solutions in the evolving domestic and global managed care markets. To learn more about COEUS and the company’s offerings, visit


COEUS Media:
Owen Murphy | 215.680.0155

Editor Details

  • Company:
    • Businesswire
Last Updated: 14-Sep-2021